Ex vivo cytokine expansion of peripheral blood Ph-negative cells in chronic myeloid leukaemia

Leukemia and Lymphoma

Volumn 32, Issue 1-2, 1998, Pages 151-157

  Mahon, François Xavier ^a   Pigeonnier Lagarde, Valérie ^a   Chahine, Hikmat ^a   Maguer Satta, Véronique ^a   Ripoche, Jean ^a   Reiffers, Josy ^a  

^a CNRS Bordeaux Segalen University   (France)

Author keywords

5 fluorouracil; Chronic myeloid leukaemia; Cytokine expansion; Ph negative cells

Indexed keywords

CD34 ANTIGEN; CYTOKINE; FLT3 LIGAND; FLUOROURACIL; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; LEUKEMIA INHIBITORY FACTOR; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; AUTOTRANSPLANTATION; BLOOD; BONE MARROW; BONE MARROW CULTURE; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTAPHERESIS; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

EID: 0032466896     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809059255     Document Type: Article

References (26)

1. Fialkow, P.J., Jacobson, R.J. and Papayannopoulou, T. (1977) Chronic myelocylic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyle, platelet and monocyte/macrophage. American Journal of Medicine, 63, 125-130.
2. De Klein, A., Geurts van Kessel, A., Grosveld, G., Bartram, C.R., Hagemeijer, A., Bootsma, D., Spurr, N.K., Heisterkamp, N., Groffen, J. and Stephenson, J.R. (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature, 300, 765-767.
3. Groffen, J., Stephenson, J.R., Heisterkamp, N., De Klein, A., Bartram, C.R. and Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 36, 93-99.
4. Thomas, E.D., Clift, R.A., Fefer, A., Appelbaum, F.R., Beatty, P., Bensinger, W.I., Buckner, C.D., Cheever, M.A., Deeg, H.J., Doney, K., Flournoy, N., Greenberg, P., Hansen, J.A., Martin, P., Mc Guffin. R., Ramberg. R., Sanders, J.E., Singer, J., Stevart, P., Storb, R. Sullivan, K., Weiden, P.L. and Witherspoon, R. (1986) Marrow transplantation for the treatment of chronic myelogenous leukemia. Annals of Internal Medecine 104, 155-162.
5. |5] Goldman, J.M., Apperley, J.F., Jones, L., Marcus, R., Goolden, A.W.G., Batchelor, R., Hale, G, Waldman, H, Reid, C.D., Hows, J., Gordon-Smith, E., Catovsky, D. and Galton, D.A.G. (1986) Bone marrow transplantation for patients with chronic myeloid leukemia. New England Journal of Medicine, 314, 202-207.
6. Mc Clave, P.B., De Fabritiis, P., Deisseroth, A., Goldman, J., Bar nett, M., Reiffers, J., Simonsson, B., Carella, C. and Aepli, D. (1994) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. The Lancet, 343, 1486-1488.
7. Deisseroth, A.B., Zu, Z., Claxton, D., Hanania, E.G., Fu, S., Ellerson, D., Goldberg, L., Thomas, M., Janicek, K., Anderson, W.F., Hester, J., Körbling, M., Durett, A., Moen, R., Berenson, R., Heimfeld, S., Hamer, J., Calvert, L., Tibbits, P., Talpaz, M., Kantarjian, H., Champlin, R, and Reading. C. (1994) Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
8. Reiffers, J., Mahon, F.X., Boiron, J.M., Fabères, C., Cony-Makhoul, P. and Broustet, A. (1996) Autografting in chronic myeloid leukemia: an overview. Leukemia, 10, 385-388.
9. Coulombel, L., Kalousek, D.K., Eaves, C.J., Gupta, C.M. and Eaves, A.C. (1983) Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive myelogenous leukemia. New England Journal of Medicine, 308, 1493-1498.
10. Turhan, A.C., Humphries, R.K., Eaves, C.J., Barnett, M.J., Phillips, G.L., Kalousek, DK. Klingemann, H.G., Lansdorp, P.L., Reece, D.E., Shepherd J.D. and Eaves, A.C. (1990) Detection of breakpoint cluster region-negative and non-clonal hematopoiesis in vitro and in vivo after transplantation of cells selected in cultures of chronic myeloid leukemia marrow. Blood, 76, 2404-2410.
11. Verfaillie, C.M., Miller, W.J., Boylan, K. and Mc Glave, P.B. (1992) Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood, 79. 1003-1010.
12. Leemhuis, T., Leibowitz, D., Cox, G., Silver, R., Srour, E.F., Tricot, G. and Hoffman, R. (1993) Identification of BCR/ABL negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood, 81, 801-807.
13. lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization. Blood, 86, 737-743.
14. Emerson, S. (1996) Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells : the next generation of cellular therapeutics. Blood, 87, 3082-3088.
15. Lange, W., Henschler, R. and Mertelsmann, R. (1996) Biological and clinical advances in stem cell expansion. Leukemia, 10, 943-945.
16. Beradi, A.C., Wang, A., Levine, J.D., Lopez, P. and Scadden, D.T. (1995) Functional isolation and characterization of human hematopoietic stem cells. Science, 267, 104-108.
17. Jazwiec, B., Mahon, F.X., Pigneux, A., Pigeonnier, V. and Reiffers, J. (1995) 5-Fluorouracil Resistant CD34 + Cell Population from peripheral blood of CML patients contains Bcr-Abl negative progenitors cells. Experimental Hematology, 23, 1509-1514.
18. Mahon F.X., Pigeonnier-Lagarde V., Chahine H., Barbot C., Jazwiec B., Ripoche. R. and Reiffers, J.(1997). Ex vivo cytokine expansion of peripheral blood 5-fluorouracil-treated-CD34 positive chronic myeloid leukaemia cells increases the selection of Ph negative cells. British Journal of Haematology, 98 : 467-473.
19. Malinge, M.C, Mahon, F.X., Delfau, M.H,. Daheron, L., Kitzis, A., Guilhot, F., Tanzer, J., Grandchamp B. (1992) Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukemia under interferon therapy. British Journal of Haematology, 82, 701-707.
20. Carlo-Stella, C., Mangoni, L., Piovani, G., Almici, C., Garau, D., Caramatti, C, and Rizzoli. V, (1991) In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplantation, 8, 265-272.
21. Rice, A., Boiron, J-M., Barbot, C., Dupouy, M., Dubosc-Marchenay, N., Dumain, P., Lacombe, F. and Reiffers, J. (1995) Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells. Experimental Hematology, 23, 303-308.
22. Shah, A.J., Smogorzewska, E.M., Hannun, C. and Crooks, G.M. (1996) FLT3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro. Blood, 87, 3563-3570.
23. Rusten, L;S., Lyman, S., Veiby, O.P. and Jacobsen, S.E. (1996) The FLT3 ligand is a direct and potent stimulator of the growth of primitive and commited human CD34+ bone marrow progenitor cells in vitro. Blood, 87, 1317-1325.
24. Petzer, A., Zandstra, P.W., Piret, J.M. and Eaves, C. (1996) Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. Journal of Experimental Medicine,183, 2551-2555.
25. Piacibello, W., Sanavio F., Garetto L. Severino A, Bergandi D., Ferrario J, Fagioli F, Berger M, and Aglietta M (1997). Extensive amplification and self reniewal of human primitive hematopoietic stem cell from cord blood. Blood; 89, 2644-2653.
26. Lewis I., D, Haylok D.N, Moore S., Hughes T.P (1997). Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia. Leukemia 11, 581-587.